| Issue Date | Title | Author(s) |
| 2012-03-01 | Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer | Montavon, C; Gloss, BS; Warton, K; Barton, CA; Statham, AL; Scurry, JP; Tabor, B; Nguyen, TV; Qu, W; Samimi, G; Hacker, NF; Sutherland, RL; Clark, SJ; O'Brien, PM |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2011-10 | Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. | Lee, HJ; Hinshelwood, RA; Bouras, T; Gallego-Ortega, D; Valdés-Mora, F; Blazek, K; Visvader, JE; Clark, SJ; Ormandy, CJ |
| 2017-11-07 | Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer. | Valdés-Mora, F; Gould, CM; Colino-Sanguino, Y; Qu, W; Song, JZ; Taylor, KM; Buske, FA; Statham, AL; Nair, SS; Armstrong, NJ; Kench, JG; Lee, KML; Horvath, LG; Qiu, M; Ilinykh, A; Yeo-Teh, NS; Gallego-Ortega, D; Stirzaker, C; Clark, SJ |
| 2015-12 | ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells. | Gallego-Ortega, D; Ledger, A; Roden, DL; Law, AMK; Magenau, A; Kikhtyak, Z; Cho, C; Allerdice, SL; Lee, HJ; Valdes-Mora, F; Herrmann, D; Salomon, R; Young, AIJ; Lee, BY; Sergio, CM; Kaplan, W; Piggin, C; Conway, JRW; Rabinovich, B; Millar, EKA; Oakes, SR; Chtanova, T; Swarbrick, A; Naylor, MJ; O'Toole, S; Green, AR; Timpson, P; Gee, JMW; Ellis, IO; Clark, SJ; Ormandy, CJ |
